Skip Nav Destination
Issues
1 May 2001
ISSN 1078-0432
EISSN 1557-3265
Editorial
The Biology Behind
The Cooperative Group Bulletin Board
Minireview
Review
Advances in Brief
Clinical Trials
Lethal Outcome of a Patient with a Complete Dihydropyrimidine Dehydrogenase (DPD) Deficiency after Administration of 5-Fluorouracil: Frequency of the Common IVS14+1G>A Mutation Causing DPD Deficiency1
André B. P. van Kuilenburg; Erik W. Muller; Janet Haasjes; Rutger Meinsma; Lida Zoetekouw; Hans R. Waterham; Frank Baas; Dick J. Richel; Albert H. van Gennip
Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment1: See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112–1115, 2001.
Uwe Wagner; Siegmund Köhler; Silke Reinartz; Patrick Giffels; Jens Huober; Kirsten Renke; Harald Schlebusch; Hans-Jürgen Biersack; Volker Möbus; Rolf Kreienberg; Thomas Bauknecht; Dieter Krebs; Diethelm Wallwiener
Alteration of Interleukin 2 (IL-2) Pharmacokinetics and Function by IL-2 Antibodies Induced after Treatment of Colorectal Carcinoma Patients with a Combination of Monoclonal Antibody 17-1A, Granulocyte Macrophage Colony-Stimulating Factor, and IL-21
Anna-Lena Hjelm Skog; Meenu Wadhwa; Moustapha Hassan; Baback Gharizadeh; Chris Bird; Peter Ragnhammar; Robin Thorpe; Håkan Mellstedt
The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma1
Margaret von Mehren; Philip Arlen; James Gulley; André Rogatko; Harry S. Cooper; Neal J. Meropol; R. Katharine Alpaugh; Monica Davey; Susan McLaughlin; Mary T. Beard; Kwong Y. Tsang; Jeffrey Schlom; Louis M. Weiner
Reduction of Paclitaxel-induced Peripheral Neuropathy with Glutamine1
Linda Vahdat; Kyriakos Papadopoulos; Dale Lange; Shelby Leuin; Elizabeth Kaufman; Diana Donovan; Deborah Frederick; Emilia Bagiella; Amy Tiersten; Gwen Nichols; Thomas Garrett; David Savage; Karen Antman; Charles S. Hesdorffer; Casilda Balmaceda
Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer1
Dong M. Shin; Nicholas J. Donato; Roman Perez-Soler; Hyung Ju C. Shin; Ji Y. Wu; Peter Zhang; Kristie Lawhorn; Fadlo R. Khuri; Bonnie S. Glisson; Jeffrey Myers; Gary Clayman; David Pfister; John Falcey; Harlan Waksal; John Mendelsohn; Waun Ki Hong
Phase I Trial of ISIS 5132, an Antisense Oligonucleotide Inhibitor of c-raf-1, Administered by 24-hour Weekly Infusion to Patients with Advanced Cancer1
Charles M. Rudin; Jon Holmlund; Gini F. Fleming; Sridhar Mani; Walter M. Stadler; Philip Schumm; Brett P. Monia; Joseph F. Johnston; Richard Geary; Rosie Z. Yu; T. Jesse Kwoh; F. Andrew Dorr; Mark J. Ratain
Phase I Pharmacokinetic Trial and Correlative in Vitro Phase II Tumor Kinetic Study of Apomine (SR-45023A), a Novel Oral Biphosphonate Anticancer Drug1
David S. Alberts; Alton V. Hallum III; Mary Stratton-Custis; Dava J. Garcia; Mary Gleason-Guzman; Sydney E. Salmon; Pedro Santabarbara; Eric J. Niesor; Simon Floret; Craig L. Bentzen
Molecular Oncology
Circulating Transforming Growth Factor β1 as a Predictor of Liver Metastasis after Resection in Colorectal Cancer
Hirofumi Tsushima; Nobuyuki Ito; Shinji Tamura; Yukihiko Matsuda; Masami Inada; Iwao Yabuuchi; Yasuharu Imai; Ryuichi Nagashima; Hiroyuki Misawa; Hiroaki Takeda; Yuji Matsuzawa; Sumio Kawata
Relation of Vascular Endothelial Growth Factor Production to Expression and Regulation of Hypoxia-inducible Factor-1α and Hypoxia-inducible Factor-2α in Human Bladder Tumors and Cell Lines1
Adam Jones; Chisato Fujiyama; Christine Blanche; John W. Moore; Sue Fuggle; David Cranston; Roy Bicknell; Adrian. L. Harris
Significant Correlation between Interleukin 10 Expression and Vascularization through Angiopoietin/TIE2 Networks in Non-small Cell Lung Cancer1
Hiroyuki Hatanaka; Yoshiyuki Abe; Masao Naruke; Tetsuji Tokunaga; Yoshiro Oshika; Tsutomu Kawakami; Hideo Osada; Junko Nagata; Jun-ichiro Kamochi; Takashi Tsuchida; Hiroshi Kijima; Hitoshi Yamazaki; Hiroshi Inoue; Yoshito Ueyama; Masato Nakamura
Coexpression of Inducible Nitric Oxide Synthase and COX-2 in Hepatocellular Carcinoma and Surrounding Liver: Possible Involvement of COX-2 in the Angiogenesis of Hepatitis C Virus-positive Cases
Md. Atiqur Rahman; Dipok Kumar Dhar; Emi Yamaguchi; Seiji Maruyama; Takashi Sato; Hikota Hayashi; Takashi Ono; Akira Yamanoi; Hitoshi Kohno; Naofumi Nagasue
Expression of MUC1 Mucins in the Subserosal Layer Correlates with Postsurgical Prognosis of Pathological Tumor Stage 2 Carcinoma of the Gallbladder1
Toru Kawamoto; Junichi Shoda; Tatsuro Irimura; Naoki Miyahara; Masato Furukawa; Tetsuya Ueda; Toru Asano; Masahito Kano; Naoto Koike; Katashi Fukao; Naomi Tanaka; Takeshi Todoroki
Experimental Therapeutics, Preclinical Pharmacology
Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents1
Kalkunte S. Srivenugopal; Jiang Shou; Srinivas R. S. Mullapudi; Frederick F. Lang, Jr.; Jasti S. Rao; Francis Ali-Osman
Effects of Dietary Curcumin on Glutathione S-Transferase and Malondialdehyde-DNA Adducts in Rat Liver and Colon Mucosa: Relationship with Drug Levels1
Ricky A. Sharma; Christopher R. Ireson; Richard D. Verschoyle; Kirsti A. Hill; Marion L. Williams; Chiara Leuratti; Margaret M. Manson; Lawrence J. Marnett; William P. Steward; Andreas Gescher
Inhibition of Growth Factor Production and Angiogenesis in Human Cancer Cells by ZD1839 (Iressa),1 a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor2
Fortunato Ciardiello; Rosa Caputo; Roberto Bianco; Vincenzo Damiano; Gabriella Fontanini; Sabina Cuccato; Sabino De Placido; A. Raffaele Bianco; Giampaolo Tortora
Cancer Biology, Immunology, Cytokines
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.